Last Updated : December 18, 2013
Details
FilesGeneric Name:
Macitentan
Project Status:
Complete
Therapeutic Area:
Pulmonary arterial hypertension
Manufacturer:
Actelion Pharmaceuticals Canada Inc.
Call for patient/clinician input open:
Brand Name:
Opsumit
Project Line:
Reimbursement Review
Project Number:
SR0364-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Pulmonary arterial hypertension
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : December 18, 2013